# Scientific and Regulatory Approach to Botanical Drug Development: A U.S. FDA Perspective

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/scientific-and-regulatory-approach-to-botanical-drug-development-a-u-s-fda/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Charles Wu,Lee Su-Lin,Cassandra Taylor,Jing Li,Yen-Ming Chan,Rajiv Agarwal,Robert Temple,Douglas C. Throckmorton,Katherine M. Tyner |
| Citations | 124 |
| DOI | 10.1021/acs.jnatprod.9b00949 |
| Fields | Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3002481323 |
| PMID | 31977211 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Lee Su-Lin](https://scholariq.org/researchers/lee-su-lin/)

## Paper primary topic

- [Herbal Medicine Research Studies](https://scholariq.org/topics/herbal-medicine-research-studies/)

## Paper topics

- [Herbal Medicine Research Studies](https://scholariq.org/topics/herbal-medicine-research-studies/)
- [Complementary and Alternative Medicine Studies](https://scholariq.org/topics/complementary-and-alternative-medicine-studies/)
- [Pharmacological Effects of Natural Compounds](https://scholariq.org/topics/pharmacological-effects-of-natural-compounds/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.